fosun pharma granted best investment value award for listed companies
on nov. 28, the “2013 chinese listed companies’ overseas summit forum & china securities golden bauhinia awards ceremony” was held in hong kong. nine awards including “the most influential listed company”, “the greatest brand value award for leading listed companies”, “the best investment value award for listed companies” and “the most socially responsible award for listed companies”, etc. were announced，of which fosun pharma was granted the best investment value award for listed companies.
with “china dream: reforms and opportunities” as the theme, the forum focused on the historical opportunities created through reforms, and explored the road to the future of global economic development. over 500 distinguished guests, including many board chairmen from well-known listed companies were present in the forum. three major topics were discussed, i.e. the ways for industrial and commercial word in the mainland and hong kong to make prospective strategic layout, how to seize commercial opportunities during economic transition, and to find investment opportunities in china in the year to come, etc.
the “china securities golden bauhinia awards ceremony” was sponsored by takungpao jointly with lcab (the listed companies association of beijing), shanghai association of stock system enterprises, the hong kong chinese enterprises association, chinese securities association of hong kong, chinese financial association of hong kong, hong kong securities professionals association and the hong kong institute of chartered secretaries. since its opening, it has been taking “a one hundred year takungpao, convergence of elites, boosting economic development and serving for the public” as the purpose, devoting to promote chinese enterprises to go global more actively and steadily.